{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:16:14Z","timestamp":1790745374027,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.thromres.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:37:04Z","timestamp":1567683424000},"page":"170-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells"],"prefix":"10.1016","volume":"187","author":[{"given":"Rania","family":"AmraneDjedidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette K.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Van Dreden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoris T.","family":"Gerotziafas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2019.09.003_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5482\/ha-1170","article-title":"Epidemiology, risk and outcomes of venous thromboembolism in cancer","volume":"32","author":"Falanga","year":"2012","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2019.09.003_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.30672","article-title":"The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy","volume":"141","author":"Moore","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.thromres.2019.09.003_bb0015","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1093133","article-title":"Nanotubular highways for intercellular organelle transport","volume":"303","author":"Rustom","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.thromres.2019.09.003_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.moh.0000131441.10020.87","article-title":"Cellular microparticles: a disseminated storage pool of bioactive vascular effectors","volume":"11","author":"Morel","year":"2004","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2302\/kjm.53.210","article-title":"New horizons in the analysis of circulating cell-derived microparticles","volume":"53","author":"Horstman","year":"2004","journal-title":"Keio J. Med."},{"key":"10.1016\/j.thromres.2019.09.003_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2008-1079260","article-title":"Tissue factor-bearing microparticles and cancer","volume":"34","author":"Zwicker","year":"2008","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.09.003_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2007.06514.x","article-title":"Plasma microparticles and vascular disorders","volume":"137","author":"Lynch","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","article-title":"Microparticle-associated tissue factor activity: a link between cancer and thrombosis?","volume":"5","author":"Tesselaar","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"22","key":"10.1016\/j.thromres.2019.09.003_bb0045","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","article-title":"Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy","volume":"15","author":"Zwicker","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.thromres.2019.09.003_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0055","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1634\/theoncologist.2017-0530","article-title":"Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: The observational ROADMAP-CAT study","volume":"23","author":"Syrigos","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.thromres.2019.09.003_bb0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.leu.2404132","article-title":"Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2019.09.003_bb0065","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00262-005-0075-9","article-title":"Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes","volume":"55","author":"Baj-Krzyworzeka","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.thromres.2019.09.003_bb0070","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1615646","article-title":"Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation","volume":"85","author":"Berckmans","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.09.003_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH06-06-0313","article-title":"Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets","volume":"97","author":"Sinauridze","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.09.003_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0049-3848(98)00108-X","article-title":"Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells","volume":"91","author":"Kagawa","year":"1998","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.09.003_bb0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.acvd.2010.06.005","article-title":"Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism","volume":"103","author":"Bal","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.thromres.2019.09.003_bb0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.thromres.2011.08.020","article-title":"Circulating microparticles and risk of venous thromboembolism","volume":"129","author":"Bucciarelli","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.09.003_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.thromres.2011.10.014","article-title":"Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis","volume":"130","author":"Ye","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.09.003_bb0100","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3892\/ijo.2017.4170","article-title":"Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer","volume":"51","author":"Rousseau","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1538-7836.2011.04610.x","article-title":"Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol","volume":"10","author":"Lacroix","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.09.003_bb0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MBC.0b013e32832e05dd","article-title":"Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction","volume":"20","author":"Van Dreden","year":"2009","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.09.003_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2141.2009.07958.x","article-title":"Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia","volume":"148","author":"Schneider","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1186\/1471-2407-14-991","article-title":"Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability","volume":"14","author":"Chaari","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.thromres.2019.09.003_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-9560-3-16","article-title":"Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay","volume":"3","author":"Gerotziafas","year":"2005","journal-title":"Thromb. J."},{"issue":"33","key":"10.1016\/j.thromres.2019.09.003_bb0130","article-title":"Extracellular vesicles: How they interact with endothelium, potentially contributing to metastatic cancer cell implants","volume":"6","author":"Bern","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.thromres.2019.09.003_bb0135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.thromres.2011.07.049","article-title":"Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7","volume":"129","author":"Gerotziafas","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.2011.055343","article-title":"Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography","volume":"97","author":"Marchetti","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2019.09.003_bb0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1160\/TH13-01-0055","article-title":"Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity","volume":"110","author":"Collier","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.09.003_bb0150","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1160\/TH07-11-0691","article-title":"Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells","volume":"100","author":"Aharon","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.09.003_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood.V96.1.170","article-title":"Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor","volume":"96","author":"Rauch","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2019.09.003_bb0160","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.274.33.23111","article-title":"Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway","volume":"274","author":"Mesri","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2019.09.003_bb0165","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/ATVBAHA.108.175083","article-title":"Contribution of host-derived tissue factor to tumour neovascularization","volume":"28","author":"Yu","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0170","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2019.09.003_bb0175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/onc.2016.253","article-title":"Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention","volume":"36","author":"Wendler","year":"2017","journal-title":"Oncogene"},{"issue":"261","key":"10.1016\/j.thromres.2019.09.003_bb0180","article-title":"Tissue factor-expressing tumor-derived extracellular vesicles activate quiescent endothelial cells via protease-activated receptor-1","volume":"7","author":"Che","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4049\/jimmunol.1301790","article-title":"Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor","volume":"192","author":"Pan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.thromres.2019.09.003_bb0190","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.V89.7.2429","article-title":"Apoptotic vascular endothelial cells become procoagulant","volume":"89","author":"Bombeli","year":"1997","journal-title":"Blood."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819303998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819303998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:00Z","timestamp":1758735900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384819303998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":38,"alternative-id":["S0049384819303998"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.09.003","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}